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The precise lineage between neural stem cells and mature astrocytes remains poorly defined. To examine astrocyte development, we have
characterized glial precursors from neural tissue derived from early embryonic ages. We show that CD44 identifies an astrocyte-restricted
precursor cell (ARP) that is committed to generating astrocytes in vitro and in vivo in both rodent and human tissue. CD44+ cells arise later
in development than neuronal-restricted precursors (NRPs) or tripotential glial-restricted precursors (GRPs). ARPs are distinguished from
GRP and NRP cells by their antigenic profile and differentiation ability. ARPs can be generated from GRP cells in mass or clonal cultures and
in vivo after transplantation, suggesting a sequential differentiation of neuroepithelial stem cells (NEPs) to GRPs to ARPs and then to
astrocytes. The properties of ARPs are different from other astrocyte precursors described previously in their expression of CD44 and S-100h
and absence of other lineage markers. Using a CD44 misexpression transgenic mouse model (CNP-CD44 mouse), we show that CD44
overexpression in vivo and in vitro decreases the number of mature glia and increases the number of O4+/GFAP+ cells tenfold.
Misexpression of CD44 in culture inhibits oligodendrocytes and arrests cells at the precursor state. In summary, our data provide strong
evidence for the existence of a CD44+ ARP in the developing nervous system.
Published by Elsevier Inc.
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Development in the nervous system involves the
sequential production of specific neural cells. The early
born neural tube cells do not express markers characteristic
of neurons, astrocytes, and oligodendrocytes but are multi-
potent and capable of generating differentiated neurons and
glial cells in vitro and in vivo (Pevny and Rao, 2003; Rao et
al., 1998). These early born stem cells, however, do not0012-1606/$ - see front matter. Published by Elsevier Inc.
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generate more restricted proximate progenitors (blast cells)
that undergo limited proliferation before maturing into fully
differentiated cells. Many such proximate progenitors have
been identified. These include neuronal precursors (Gage et
al., 1995; Mayer-Proschel et al., 1997; Rao, 1999; Ray and
Gage, 1994; Yang et al., 2000), oligodendrocyte precursors
(Liu and Rao, 2003a; Liu and Rao, 2004; Lu et al., 2002;
Raff et al., 1983; Rowitch et al., 2002; Zhou and Anderson,
2002), and astrocyte precursors (Alfei et al., 1999; Mi and
Barres, 1999; Seidman et al., 1997). Intermediate precursors
such as neuronal-restricted precursors (NRPs) and glial-
restricted precursors (GRPs) have been characterized in
detail, and a lineage relationship between earlier multipotent
precursor cells and more restricted progenitor cells has been276 (2004) 31–46
Y. Liu et al. / Developmental Biology 276 (2004) 31–4632established by clonal analysis, retroviral labeling, and
transplant experiments (Han et al., 2002, 2004; Mayer-
Proschel et al., 1997; Rao et al., 1998).
The development of astrocytes remains less clear.
Astrocytes may be derived from maturing radial glia (Voigt,
1989) or from distinct astrocyte precursors, whose existence
in the brain has been inferred by retroviral lineage studies,
which identify astrocyte-only clones in vivo (Levison and
Goldman, 1993, 1997) and the isolation of potential
astrocyte precursor cells from the optic nerve (Barres et
al., 1996). It is also possible that multiple lineages for
astrocytes may exist, which would be consistent with the
existence of multiple classes of astrocytes (Miller et al.,
1994), whose distribution and temporal development cannot
be readily explained by a single lineal path (Rajan and
McKay, 1998).
The ability to distinguish between these possibilities has
been hampered by the lack of available markers that can be
used to separate early precursor populations in vitro and in
vivo. More recent experiments identify CD44, a trans-
membrane glycoprotein implicated in cell–matrix adhesion
and matrix-mediated cell signaling (for review, see Naor et
al., 1997), as an early marker of astrocyte differentiation
(Alfei et al., 1999; Moretto et al., 1993; Vogel et al., 1992).
To understand the lineage relationship between bipoten-
tial glial and unipotential astrocyte precursors, we have
utilized antibodies against CD44 to identify and isolate
CD44-positive cells. We show that CD44+ cells are
astrocyte-restricted precursors (ARP) present in the devel-
oping rodent spinal cord before the acquisition of GFAP
immunoreactivity. CD44+ cells can be generated from
GRPs and can be distinguished from GRP cells by antigen
expression, cytokine dependence, and differentiation ability.
Additionally, using a CD44 misexpression transgenic mouse
model, we show that CD44 biases GRPs toward an
astrocytic fate. Combined, our data provide strong evidence
for the existence of a CD44+ ARP in the developing
nervous system.Materials and methods
Animals
Animal experiments were performed according to an
approved ACUC animal protocol. C57BL/6 mice were
purchased from NCI. Fisher 344 and timed pregnant
Sprague–Dawley rats were purchased from Harlan (Indian-
apolis, IN). Human placental alkaline phosphatase (AP)
transgenic Fisher 344 rats were generated and maintained as
described (Kisseberth et al., 1999; Mujtaba et al., 2002).
CNP-CD44 transgenic mice were generated as previously
described (Tuohy et al., 2004). Briefly, mouse CD44 cDNA
was cloned under the control of the mouse 2V,3V-cyclic
nucleotide-3V-phosphodiesterase (CNP) promoter, which was
then linearized and used to generate founders. Founderswere identified by Southern blot analysis of tail DNA using
standard procedures.
Gene detection by RT-PCR
To analyze CD44 mRNA expression levels, reverse
transcription-polymerase chain reaction (RT-PCR) was per-
formed using RNA isolated from P1 wild-type rat spinal cord
using the forward primer: 5V-CAGACCTGCCCAATGCCT
TTG ATG GAC C-3Vand the reverse primer: 5V-CAA AGC
CAAGGC CAAGAGGGATGC C-3V. GAPDHwas used as
an internal control. PCR was performed with the following
conditions: 948C, 1 min; 628C, 1 min; and 728C, 2.5 min, for
30 cycles. The product is about 950 bp. The primers for
amplification of CNP is 5V-CTTACAAGATCATCCCTG-3V
and 5V-AAG TAG AGT GGC AGA AAG T-3V. The product is
312 bp.
Cultures of neural precursor cells
Rodent neural precursor cells were isolated as described
previously (Kalyani et al., 1998; Mayer-Proschel et al.,
1997). Briefly, E14.5 time-pregnant Sprague–Dawley neural
tubes were isolated and incubated in 0.05% Trypsin EDTA
(Invitrogen) at 378C for 10 min. Excess trypsin were
removed and tissue fragments were triturated in NEP basal
medium (NEP, Kalyani et al., 1998) to obtain a suspension
of single cells. Cells were grown in NEP basal medium
supplemented with basic fibroblast growth factor (bFGF, 20
ng/ml, Peprotech, Rocky Hill, NJ). To induce oligodendro-
cyte differentiation, human platelet derived growth factor
BB (PDGF BB, 10 ng/ml, Upstate Biotechnology, Lake
Placid, NY) and 3,3,5 triiodothyronine (T3, 30 ng/ml,
Sigma, St. Louis, MO) were added. To promote astrocyte
differentiation, 10% fetal calf serum (Sigma) was added. To
induce neuronal differentiation, retinoic acid (RA, 17.5 ng/
ml; Sigma) and neurotrophin 3 (NT 3, 10 ng/ml; Peprotech)
were added.
Human neural precursor cells were purchased from
ScienCell Research Laboratories (San Diego, CA). Experi-
ments involving human cells were performed in accordance
with principles embodied in the Declaration of Helsinki
(Code of Ethics of the World Medical Association). Cells
were maintained in human neural precursor cell medium
(ScienCell Research Laboratories) supplemented by 1%
fetal bovine serum. After 20 days in culture, almost all cells
became CD44+ and did not express neuronal or glial cell
markers. These cells were used for transplantation into adult
rat spinal cord (see below).
Cell sorting by flow cytometry
Purification of A2B5+ GRP cells was performed as
described (Cai et al., 2002). Briefly, to isolate A2B5+ GRPs,
E14.5 spinal cords from wild-type timed pregnant Sprague–
Dawley rats (for mass culture and clonal analysis) or timed-
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ments) were acutely dissociated and incubated with A2B5
antibodies (1:20, ATCC hybridoma supernatant) at 48C for 1
h. The unbound antibodies were washed out and the cells
incubated in FITC-conjugated antimouse IgM secondary
antibody (1:200, Jackson ImmunoResearch, West Grove,
PA) for 30 min. After washing, the cells were resuspended
in 5% FBS in 1 PBS at a density of 0.5  107 to 1  107
per milliliter. Cell purification was performed with a
FACSstarPlus cell sorter (Becton Dickinson Immunocyto-
metry Systems, San Jose, CA) at 48C at a rate of 2500 cells/
s. The cells were collected at 48C and A2B5+ sorted cells
were checked by immunostaining and found to have a purity
of 90–99%.
To isolate CD44+ cells, dissociated E14.5 spinal cord
cells were plated on poly-l-lysine and laminin-coated
dishes and cultured in NEP basal medium in the presence
of 20 ng/ml bFGF for 24 h, then cells were grown for 3
days in NEP basal medium supplemented with bFGF (20
ng/ml) and bone morphogenetic protein 2 (BMP-2, 20
ng/ml, R&D Systems, Minneapolis, MN). Medium was
changed every other day. The cells were dissociated by
trypsin digestion and were then incubated with CD44
antibodies (2.5 Ag/ml, Chemicon, Temecula, CA) at 48C
for 1 h. The unbound antibodies were washed out. The
cells were incubated in Alexa-488 antimouse IgG
secondary antibody (1:500, Molecular Probes, Eugene,
OR) for 30 min. Then CD44+ cells were sorted using a
method similar to that described above for A2B5+ cells.
CD44+ sorted cells were checked by immunostaining and
found to have a purity of N95%. Purified A2B5+ or
CD44+ cells were plated in NEP basal medium for mass
culture, clonal analysis, and transplantation.
Clonal cultures of neural precursor cell
Flow-cytometry-purified cells or unsorted control cells
were plated at 1 cell/well in 96-well plates, maintained in
NEP supplemented with bFGF (20 ng/ml) for 7 days, and
then bFGF was withdrawn and differentiating factors (RA,
17.5 ng/ml; NT-3, 10 ng/ml; PDGF-BB, 10 ng/ml; T3, 30
ng/ml) were added. The cells were cultured for an additional
10–14 days before processed for immunocytochemistry as
described below. In general, about 50% of single cells
survive the cloning process, which is similar to other cells
subjected to clonal analysis (Kalyani et al., 1997).
Intraspinal grafting into the adult intact spinal cord
Transplantation was performed as described before
(Han et al., 2004). Briefly, flow cytometry purified rat
A2B5+ or CD44+ cells or human CD44+ cells main-
tained in culture were dissociated and resuspended in
fresh culture media at a concentration of 25,000 cells/Al.
Adult female Sprague–Dawley rats were anesthetized and
a single dose of cells was microinjected into the cervicalspinal cord. Animals received Buprenex and were
immunosuppressed with Cyclosporin A (Sandoz Pharma-
ceuticals, East Hanover, NJ).
Posttransplantation analysis
Animals were sacrificed at 2 and 4 weeks, perfused with
4% paraformaldehyde, and cryoprotected in 30% sucrose–
0.1 M phosphate buffer at 48C for 3 days (Han et al., 2004).
Spinal cord fragments centered at the injection site were
identified and embedded in O.C.T. (Fisher Scientific).
Blocks were processed for AP histochemistry and immu-
nohistochemistry analysis.
Immunohistochemistry and immunocytochemistry
Spinal cord and brain tissues were dissected and fixed
with 4% paraformaldehyde, cryoprotected with 30%
sucrose, and embedded in O.C.T. as described (Liu et al.,
2002). Cultured cells were isolated and processed for
immunocytochemistry as described previously (Mayer-
Proschel et al., 1997). BrdU incorporation assay was
performed as described (Cai et al., 2002). The following
antibodies were used: A2B5 (1:20, ATCC); AP (1:100,
Accurate, Westbury, NY); BrdU (1:5, Developmental
Studies Hybridoma Bank, DSHB, Iowa); CD44 (1:200,
Chemicon; 1:25, IM7 hybridoma supernatant; 1:25,
Hermes-3 hybridoma supernatant); E-NCAM (PSA-NCAM,
polysialylated neural cell adhesion molecule, 5A5, 1:5,
DSHB); GalC (galactocerebroside, 1:5, kind gift of Dr. B.
Ranscht, The Burnham Institute); GFAP (1:4000, DAKO,
Carpinteria, CA; or 1:200, BD Pharmingen); GLAST
(1:500, Dr. J. Rothstein, Johns Hopkins University); hNUC
(human nuclei specific antibody, 1:20, Chemicon); Ki-67
(1:25, DAKO); MAP2 (1:100, Sigma); MBP (myelin basic
protein, 1:25, Chemicon); NeuN (1:100, Sigma); Nestin
(1:5, DSHB); NG2 (1:2000, kind gift of Dr. W. Stallcup);
Nkx2.2 (1:1, DSHB); NF160 (neurofilament, 1:500,
Sigma); Olig2 (1:8000, kind gift of Dr. D. Rowitch, Dana-
Farber Cancer Institute); PDGFRa (platelet derived growth
factor receptor a, 1:200, BD Pharmingen); RC1 (1:200,
DSHB); RC2 (1:25, DSHB); S-100h (1:200, Sigma); Sox1
(1:1000, Dr. L. Pevny, University of North Carolina); Sox2
(1:2000, Dr. Pevny). The following secondary antibodies
were used: antimouse IgG 568 or 488 (1:500, Molecular
Probes); anti-rabbit IgG 568 or 488 (1:500, Molecular
Probes); FITC- or TRITC-conjugated antimouse IgG1, or
IgG2a, or IgG2b or IgG3 (1:200, Southern Biotechnology);
FITC- or TRITC-conjugated anti-rat IgG (1:200, Jackson
ImmunoResearch); FITC-, Cy2-, Cy3-, or Cy5-conjugated
anti-mouse IgM (1:200, Jackson ImmunoResearch). Bis-
benzamide (1:1000, Sigma) or To-Pro 3 (1:5000, Molecular
Probes) was used to identify the nuclei. Images were
captured and processed using an Olympus Fluoview
confocal laser scanning system or an Olympus fluorescence
microscope.
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Whole brains were minced on ice, homogenized, and
lysed in ice cold 50 mM Tris–HCl pH 7.4 containing 150
mM NaCl, 0.5% Nonidet P-40, 1 mM phenyl-methylsul-
fonyl fluoride, and 10 Ag/ml leupeptin. Lysates were then
analyzed by SDS-polyacrylamide gel electrophoresis and
Western blotting as previously described (Sherman et al.,
2000). Anti-GFAP was used at 1:500 (DAKO).
Flow cytometry to quantify double-positive cells
Whole brains were dissected and dissociated into single
cells as described (Tuohy et al., 2004). To quantify
double-positive cells, dissociated cells were incubated
with GalC or O4 and GFAP primary and appropriate
secondary antibodies as previously described (Sherman et
al., 1995), then z10,000 cells were counted for fluores-
cence in all three channels using a FACS Calibur
cytometer (BD Biosciences).Results
Expression of CD44 is restricted to the astrocyte lineage in
vivo and in vitro
CD44 is expressed early (E10) during chicken embryonic
spinal cord development and appears to identify astrocyte
precursor cells (Alfei et al., 1999). To determine whether
CD44 could be used to identify an astrocyte precursor
population in rodents, we examined its expression by
immunocytochemistry using developing mouse and rat
neural tubes from E10.5 onward (Figs. 1A–E). Expression
was seen as early as E11.5 in rat (Liu et al., 2002) and E15.5
in mouse (Fig. 1B) well before the expression of GFAP (Liu
et al., 2002). Among all the splice variants of CD44, only
the standard form of CD44 (CD44s) was detected by RT-
PCR (Fig. 1F, lane 4 and data not shown).
In mice, CD44 expression was first seen in the dorsal
horn and dorsal gray matter, with a more ventral distribution
later in development (Fig. 1C). At this stage, CD44
expression did not colocalize with markers specific to the
neuronal lineage, such as h-III tubulin, E-NCAM and
NeuN, or oligodendroglial lineage, such as PDGFRa, NG2,
Sox10, GalC, O4, MBP (Liu et al., 2002 and data not
shown). By P1, many cells in the ventral white matter
coexpressed CD44 and GFAP, the mature astrocyte marker
(Figs. 1C–E; Liu et al., 2002). Even at this stage, CD44+
cells did not colabel with markers of either neuronal or
oligodendrocyte lineage (Liu et al., 2002, summarized in
Fig. 1I), suggesting that CD44 is expressed in the astrocyte
lineage and its expression precedes the GFAP expression.
To assess the differentiation potential of CD44-express-
ing cells more directly, we purified CD44+ cells by flow
cytometry sorting (see Materials and methods) and exam-ined their ability to differentiate in mass and clonal cultures.
Sorted CD44+ cells from E14.5 rat spinal cord plated in
NEP basal medium supplemented with bFGF (20 ng/ml)
divided and proliferated in culture as shown by their ability
to incorporate BrdU (Fig. 1H). Double labeling of undiffer-
entiated CD44+ cells showed that these cells expressed
some astrocytic markers but did not express markers
characteristic of the neuronal or oligodendroglial lineages
(Fig. 1I). CD44+ cells could be maintained in an undiffer-
entiated state over multiple passages in NEP basal medium
in the presence of bFGF (20 ng/ml). When induced to
differentiate in media that promote neuronal differentiation
(NEP with 17.5 ng/ml RA and 10 ng/ml NT-3), or
oligodendrocyte differentiation (NEP with 10 ng/ml
PDGF-BB and 30 ng/ml T3), or astrocyte differentiation
(NEP with 10% fetal calf serum), CD44+ cells, unlike stem
cells or GRP cells, differentiated almost exclusively into
astrocytes as assessed by GFAP expression (Figs. 1J–L)
under any of the above conditions. No neuronal or
oligodendrocyte differentiation was seen. In contrast,
unsorted cells were able to generate neurons, oligodendro-
cytes, and astrocytes (Fig. 1G) under identical culture
conditions. Previous reports also showed that NRPs differ-
entiated into neurons and GRPs into oligodendrocytes and
astrocytes, respectively, in these conditions (Mayer-Proschel
et al., 1997; Rao et al., 1998; data not shown). Thus, CD44+
cells are a dividing population that is biased in its differ-
entiation potential to generate astrocytes but not oligoden-
drocytes or neurons in culture in vitro.
To further confirm the differentiation potential of CD44+
cells, we repeated clonal analysis in three independent
experiments using sorted CD44+ cells (purity N 95%).
CD44+ sorted cells were plated at 1 cell/well in 96-well
plates, propagated in NEP supplemented with bFGF (20 ng/
ml) for 7 days, allowed to differentiate in differentiating
medium containing RA (17.5 ng/ml), NT-3(10 ng/ml),
PDGF-BB (10 ng/ml), and T3 (30 ng/ml) for an additional
10–14 days before they were processed for immunocyto-
chemistry analysis.
All 107 clones tracked showed differentiation into
GFAP+ astrocytes and greater than 90% differentiated
solely into astrocytes. Only 2/107 (1.87%) contained an
occasional h-III tubulin immunoreactive cell, and 6/107
(5.61%) of them a few GalC immunoreactive cells. In
contrast, when we analyzed the clones obtained from
unsorted cells, significantly more clones are positive for
h-III tubulin (16/53, 30.19%) or GalC (10/53, 18.87%).
Thus, in both mass and clonal culture, the differentiation
potential of CD44+ cells isolated from rat developing spinal
cord is biased to an astrocyte lineage in vitro.
CD44-expressing cells generate astrocytes but not
oligodendrocytes or neurons in vivo
To determine whether the in vitro results predicted the
behavior of CD44+ cells in vivo, we examined the ability
Fig. 1. CD44 is expressed in mouse and rat cells of astrocyte lineage. CD44 expression could not be detected until E15.5 in mouse dorsal spinal cord (A, B) and
the first appearance of CD44-positive expression was detected in the dorsal gray matter (B). At P1, CD44+ cells could be found in ventral cord and coexpressed
the astrocyte marker GFAP (C–E). Sorted CD44+ cells dissociated from E14.5 rat spinal cord were able to incorporate BrdU (H) and did not coexpress
oligodendrocyte markers Olig2, Nkx2.2, and GalC or neuronal marker h-III tubulin (I), but they differentiated into GFAP+ astrocytes in culture (J–L), while
unsorted cells from E14.5 rat spinal cord (G) gave rise to cells of neuronal (h-III tubulin, green), oligodendrocytic (GalC, red), and astrocytic (GFAP, blue)
lineages. Because CD44 is a cell membrane protein and GFAP is a cytoplasmic protein, double-labeled cells did not necessarily show yellow staining in the
picture. An example of a cell coexpressing CD44 and GFAP was designated by arrow and high-magnification pictures were shown in K and L. RT-PCR further
showed that the CD44 molecule that was expressed in rodent spinal cords was the standard form of CD44 (F), lane 1, plasmid DNA; lane 2, control without
RNA; lane 3, control without Taq; lane 4, P1 rat spinal cord cDNA. Scale bar, A–E, 200 Am; G, H, J–L, 100 Am.
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the adult rat spinal cord. The spinal cord was selected
because we have previously shown that two other
lineage-restricted precursors, NRP cells and GRP cells,
were able to survive, proliferate, and differentiate into
predicted cells types in the adult spinal cord environment
after transplantation (Han et al., 2002, 2004; Mujtaba et
al., 2002). To follow transplanted cells in vivo, we
prepared CD44+ cells from E14.5 AP transgenic rats
(Kisseberth et al., 1999). These cells, marked by APexpression, can be easily and permanently distinguished
from the wild-type host cells by AP histology or
immunohistochemistry (Kisseberth et al., 1999; Mujtaba
et al., 2002). Sorted CD44+ cells from E14.5 AP rat
embryos were then grafted into adult rat spinal cord (n =
8 per time point, total n = 16) and their differentiation
assessed. Two and 4 weeks posttransplantation, sagittal
sections (average 50 sections per rat, with 10–12 sections
containing transplanted cells per animal of a 10-mm-long
spinal cord fragment) were collected for immunocyto-
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immunostaining. Two weeks posttransplantation, coex-
pression of AP with CD44+ and S-100h were readily
detected, and occasional AP+ donor cells had begun to
express GFAP (data not shown). However, at 4 weeks
posttransplantation, many more GFAP+/AP+ cells were
seen (Figs. 2A–CU and data not shown), indicating these
grafted cells have progressed toward maturation along the
astrocyte lineage. In contrast, no transplanted cells (eight
animals, four to six sections each) appeared to have
differentiated into neurons or oligodendrocytes (Figs. 2D–
IU). To confirm the double labeling of astrocyte markers
with AP, the donor cell marker, we used confocal
microscopy to reconstruct overlap of the two markers
in double-labeled cells (Fig. 2). Astrocytes have smallFig. 2. CD44+ cells derived from AP transgenic rats give rise to astrocytes after
grafted to cervical fragment of adult Sprague–Dawley rat spinal cords. Four week
fragment centered at the injection site were processed for immunocytochemistry.
astrocyte marker GFAP (A–C), as shown by confocal images of three axes x–y (C
markers h-III tubulin (D–F, FV, FU) or oligodendrocyte marker MBP (G–I, IV, IU). Scell bodies and large number of processes making it
difficult to quantify exact numbers of double-positive
cells. However, all animals (n = 16) grafted showed
differentiation into astrocytes and none showed differ-
entiation into neurons or oligodendrocytes. Thus, as in
vitro, CD44+ cells from AP transgenic rats are biased to
the astrocyte lineage after transplantation.
CD44+ astrocyte precursors are derived from A2B5+ GRP
cells in vitro
We have previously shown that A2B5-immunoreactive
GRP cells differentiate into oligodendrocytes and astro-
cytes (Rao et al., 1998; Wu et al., 2002), both in vitro
and in vivo. Our present results raised the possibility thattransplantation. Sorted CD44+ cells from E14.5 AP rat spinal cords were
s posttransplantation, sagittal sections from a 10-mm-long host spinal cord
Donor cells as traced by AP immunoreactivity migrated and coexpressed
), x–z (CV), and y–z (CU). However, no coexpression was found with neuron
cale bar, 50 Am.
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astrocyte precursors. To test this hypothesis, we purified
A2B5 immunoreactive cells by flow cytometry sorting as
described previously (Cai et al., 2003; Wu et al., 2003)Fig. 3. A2B5+ GRP cells generate CD44+ cells in both mass and clonal culture. E
Eight hours after plating, greater than 99% of the cells in culture were A2B5 imm
majority of the cells had obtained CD44 immunoreactivity (D–F); by 7 days of
analysis was also performed using A2B5+ sorted cells. Top row shows phase con
and the bottom row CD44 immunostaining. By comparing A2B5 and CD44 stainin
A2B5+ cell (AV, DV, GV, JV, and MV), gradually lost A2B5 immunoreactivity (BV, EV, HV, K
I, 100 Am; AV–OV, 50 Am.and examined the ability of these A2B5+ cells to
differentiate into CD44+ cells. Sorted A2B5+ cells did
not express PSA-NCAM or radial glial markers (data not
shown). After sorting, the A2B5+ cells were plated in14.5 rat spinal cord cells were dissociated and sorted to isolate A2B5+ cells.
unoreactive (A) and no cells coexpressed CD44 (B). By 5 days of culture, a
culture, CD44+ cells differentiated into GFAP+ astrocytes (G–I). Clonal
trast images, the middle row shows A2B5 immunostaining of live colonies,
g, one can see that during the 3 days in culture, cells expanded from a single
V, and NV), and acquired CD44 expression (CV, FV, IV, LV, and OV). Scale bar in A–
Fig. 4. BMP and LIF promote differentiation of A2B5+ cells. A2B5+
sorted cells were treated with bFGF (2 ng/ml, lanes 1 and 2); BMP-2 (20
ng/ml) and bFGF (2 ng/ml, lanes 3 and 4); LIF (20 ng/ml) and bFGF (2
ng/ml, lanes 5 and 6); BMP-2 (20 ng/ml), LIF (20 ng/ml) and bFGF (2 ng/
ml, lanes 7 and 8) respectively. By the end of the 3-day treatment, BMP
has significantly promoted the acquisition of CD44 expression (lane 1 and
3, P b 0.05). Treatment with LIF alone also promoted the acquisition of
CD44 expression but not as dramatically as BMP treatment (lanes 1 and
5). BMP treatment alone did not induce the acquisition of GFAP
significantly (lanes 2 and 4, P N 0.05), while a combination of BMP
and LIF treatment promoted acquisition of both CD44 and GFAP
expression (lanes 1 and 7, P b 0.001; lanes 2 and 8, P b 0.05). The
graph represents five independent experiments and the value represents
mean F SE. Two-sample t tests were performed.
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99% of the cells were A2B5 immunoreactive and these
cells did not express detectable levels of CD44 (Figs.
3A–C). These cells were maintained in NEP basal
medium supplemented with bFGF (20 ng/ml) and BMP-
2 (20 ng/ml), most A2B5+ cells differentiated into CD44
expressing cells by day 5, of which a small percentage
colabeled for A2B5 and CD44, indicating the existence
of the transition state (Figs. 3D–F). After 7 days in vitro,
virtually all cells became GFAP+ astrocytes (Figs. 3G–I),
and many cells were GFAP+/CD44+. No transitional
A2B5+/CD44+ cells could be detected at this time. Our
clonal culture results (total 50 clones) further confirmed
the mass culture data. An example of a clone we
followed is shown in Figs. 3AV–OV. Single A2B5+ cells
proliferated to form a colony, and in differentiation
conditions gradually lost A2B5 immunoreactivity and
acquired CD44 expression (Figs. 3AV–OV). As in mass
culture, cells passed through a stage where they coex-
pressed A2B5 and CD44 (compare Figs. 3KV,LV) before
they became CD44+/A2B5- (Figs. 3NV,OV). To exclude the
possibility that A2B5+ cells may include some neuronal
cells, we repeated the experiments using double selection
to obtain A2B5 immunoreactive and E-NCAM negative
cells. Results obtained confirmed that A2B5+ glial
precursors generate CD44+ astrocyte precursors that
subsequently mature to acquire GFAP immunoreactivity.
The transition from A2B5+ to CD44+ to GFAP+ is
regulated by BMP and leukemia inhibitory factor (LIF)
To elucidate the factors that are important in the
transition from A2B5+ GRP cells to CD44+ astrocyte
restricted precursors and then GFAP+ astrocytes, we
tested the potential of two growth factors, BMP and
LIF, which have been shown to promote astrocyte
differentiation (Mehler et al., 1997; Richards et al.,
1996). A2B5+ GRP cells were harvested as described
previously and maintained in NEP in the presence of 20
ng/ml bFGF for 24 h after sorting and then treated
differently: in FGF group (lanes 1 and 2 in Fig. 4), cells
were grown in NEP/bFGF alone (2 ng/ml, to decrease
self-renewal but sufficient for cell survival); in BMP
group (lanes 3 and 4 in Fig. 4), cells were grown in NEP,
bFGF (2 ng/ml), and BMP-2 (20 ng/ml); in LIF group
(lanes 5 and 6 in Fig. 4), LIF (20 ng/ml, R&D systems)
were added in the place of BMP; and in BMP+LIF group
(lanes 7 and 8 in Fig. 4), both BMP (20 ng/ml) and LIF
(20 ng/ml) were added to NEP/bFGF (2 ng/ml). GFAP
and CD44 expressions were examined by immunohisto-
chemistry after 3 days, the cells expressing CD44 or
GFAP were counted and the numbers analyzed for
significance by Student’s t tests. Treatment with BMP
alone promoted the acquisition of CD44 immunoreactivity
as indicated by the increased numbers of CD44+ cells
(Fig. 4, lanes 1 and 3, P b 0.05). However, no significantup-regulation of the number of GFAP-expressing cells
was seen (Fig. 4, lanes 2 and 4, P N 0.05; also lanes 3
and 4, P b 0.05). Treatment with LIF alone promoted
both CD44 and GFAP expression, but the increased
number of CD44-expressing cells was not as dramatic
as in cells treated with BMP (Fig. 4, lanes 5 and 6). In
contrast, BMP and LIF in combination significantly
elevated the number of both CD44+ and GFAP+ (Fig.
4, lanes 1 and 7, P b 0.001; lanes 2 and 8, P b 0.05).
Thus, BMP and LIF both promote astrocyte differentiation
and their effects are synergistic with BMP causing a
down-regulation of the number of A2B5 immunoreactive
cells and an increase of the number of CD44+ cells, with
LIF mainly promoting the number of GFAP-expressing
cells. The statistic results are based on five independent
experiments. These data are consistent with previous
reports that suggest that, in telencephalic neural stem
cells, BMP alone only induces astrocyte differentiation to
a certain intermediate stage and additional signal(s) is
needed for further maturation (Nakashima et al., 2001).
A2B5+ GRP cells generate CD44+ astrocyte precursors in
vivo
Our previous results have shown that A2B5+ GRP cells,
unlike oligodendrocyte type-2 astrocyte precursors (O-2As),
generate astrocytes in vivo (Rao et al., 1998) and our present
results suggest that they do so by first generating a CD44+
Y. Liu et al. / Developmental Biology 276 (2004) 31–46 39precursor cell. To confirm that as in vitro, A2B5+ glial
progenitor cells transit through a CD44+ stage, we trans-
planted A2B5+/CD44 GRP cells harvested from AP
transgenic rats (Kisseberth et al., 1999; Mujtaba et al.,
2002) into adult rat spinal cord (Fig. 5). Animals (n = 8)
were sacrificed at 2 weeks posttransplantation. Sagittal
sections (averaged 10–12 sections per rat) of a 10-mm-long
spinal cord segment, where A2B5+ cells were grafted, were
collected to assess the phenotype of transplanted cells.
Consistent with the in vitro data, these transplanted A2B5+
cells acquired CD44 and GFAP expression and differ-
entiated into astrocytes (Figs. 5D–I). As previously
described and in contrast to our experiments with trans-
planted NRPs (Han et al., 2002), no neuronal differentiation
was seen (Figs. 5J–L). Thus, signals exist to direct theFig. 5. A2B5+ rat GRP cells generate CD44+ cells after transplantation into adult
rats and A2B5+ cells were sorted for engraftment into adult Sprague–Dawley rat
alkaline phosphatase (A) and more than 90% of the sorted AP cells are A2B5+ (B)
were sacrificed 4 weeks posttransplantation and sagittal sections from s
immunocytochemistry. After transplantation, the grafted cells, as identified by A
GFAP+ cells (H, I) or Sox10+ oligodendrocyte precursors (not shown), but did no
Scale bar in A, 100 Am; B and C, 50 Am; D–L, 100 Am.differentiation of A2B5+ GRP cells into astrocytes in vivo
and the differentiation involves the acquisition of CD44
immunoreactivity.
Misexpression of CD44 in glial progenitors alters
differentiation of oligodendrocytes and astrocytes
To further evaluate the role of CD44 in the differentiation
of astrocytes, we utilized the CNP-CD44 transgenic mouse
model. In this model, CD44 is expressed under the control
of the CNP promoter that drives CD44 expression in glial
progenitors as early as E12.5 in mouse (Chandross et al.,
1999; Tuohy et al., 2004), and RT-PCR and immunocy-
tochemistry showed that CNP is also expressed in both
mouse and rat A2B5+ glial precursors (Fig. 7A). Bothrat spinal cord. E14.5 spinal cord cells were dissociated from AP transgenic
spinal cord. Before transplantation, about 75% of the cells are positive for
, while less than 1% of the cells expressed GFAP (B) or CD44 (C). Animals
pinal cord fragments containing injection sites were processed for
P immunoreactivity (D, G, and J), differentiated into CD44+ (E, F) and
t give rise to neurons as assessed by h-III tubulin immunoreactivity (K, L).
Y. Liu et al. / Developmental Biology 276 (2004) 31–4640heterozygous and homozygous mice show a twofold to
fourfold increase in CD44 expression in the CNS at P1
(Tuohy et al., 2004). This overexpression persists till
adulthood and leads to a severe demyelination with an
associated accumulation of oligodendrocyte precursors as
assessed by expression of PDGFRa, Nkx2.2, Sox10, O4,Fig. 6. Increased number of astrocytes and accumulation of oligodendrocyte precu
transgenic and wild-type mouse spinal cords were dissociated and double labeled
GFAP in heterozygous and homozygous mice than wild-type animals, as
Immunohistochemistry shows that the number of PDGFRa+ oligodendrocyte pr
(B). The number of astrocytes, especially the gray matter astrocytes, also increase
bar, 200 Am.and GalC (Figs. 6B and 7J,K; Tuohy et al., 2004),
suggesting that CD44 misexpression prevents further
maturation of glial progenitors. Because CD44 expression
signals a bias to the astrocyte lineage, we examined this
mutant to assess whether the failure to mature into
oligodendrocytes and accumulation of precursors wasrsors in 1-month-old CNP-CD44 mice. Cells from 1-month-old CNP-CD44
with GalC and GFAP (A). About 10-fold more cells coexpressed GalC and
shown in the upper right quadrant of each flow cytometry graph.
ecursors increased in both heterozygous and homozygous transgenic mice
d dramatically in transgenic animals as shown by GFAP staining (C). Scale
Y. Liu et al. / Developmental Biology 276 (2004) 31–46 41associated with an increase in differentiation into astrocytes.
One-month-old transgenic animals (before overt demyeli-
nation and any potential inflammatory response) were
examined for GFAP expression and for the presence of
double labeled GalC+/GFAP+ or O4+/GFAP+ cells. Con-
sistent with our hypothesis, we observed a 10-fold increase
in the coexpression of GalC and GFAP or O4 and GFAP in
transgenic animals (Fig. 6A). Also consistently noted was a
twofold increase in numbers of GFAP-expressing cells by
flow cytometry analysis (Figs. 7B and C, labeling intensityFig. 7. Overexpression of CD44 alters cell fate both in vitro and in vivo. A2B5+/
CD44 and H2B-GFP (which drives GFP expression in the nucleus), and wer
differentiation (I). Cells overexpressing CD44 (with green fluorescence in the nucl
express any mature oligodendrocyte markers, while nontransfected cells became O
this in vivo, we used CNP-CD44 transgenic mice where the CNP promoter drives
shown by RT-PCR in (A). Brains of 1-month-old homozygous CNP-CD44 transge
and flow cytometry to assess the difference of the expression of MBP and astrocyte
diencephalon; (E and G) are from the wild-type mouse brains of the areas indica
transgenic mouse brains. Both areas show elevated GFAP expression in transgen
areas confirmed that twofold to threefold increases of GFAP expression were
cytometry analysis also showed twofold increase in GFAP expression (B and C
homozygous transgenic animals (J and K).over background, wild type 33%, and CNP-CD44 mice
66%) and an increase in GFAP immunoreactivity partic-
ularly in the gray matter by immunostaining (Figs. 6C and
7E–H).
To test the effect of CD44 misexpression more directly,
we transfected CD44 (along with H2B-GFP, which drives
GFP expression in the nucleus) into A2B5+/O4+/O1/
MBP cells, then challenged them to differentiate in the
presence of ciliary neurotrophic factor (CNTF) and T3 to
become oligodendrocytes. Nontransfected cells became O1O4+/O1/MBP cells isolated from mouse cortex were cotransfected with
e grown in the presence of CNTF and T3 to promote oligodendrocyte
ei and CD44 staining in the cytoplasm as designated by (arrowhead) did not
1 positive (green, arrow) and MBP positive (not shown). In order to confirm
expression of CD44 in A2B5+ glial progenitors or later-appearing glial cells
nic mice and their wild-type littermates were processed for immunostaining
marker GFAP. E–H show the representative staining of GFAP in the rostral
ted in (D); (F and H) are from the corresponding areas of the CNP-CD44
ic samples. Statistical t test analysis of the fluorescence density of 10 such
found in transgenics. Consistent with the immunostaining data, the flow
). In contrast, demyelination as assessed by MBP staining was obvious in
Fig. 8. Human CD44+ cells share similar properties with their rodent counterparts. CD44+ cells derived from commercially available human neural precursors
were able to incorporate BrdU (A), expressed nestin (B), did not colabel with GRP cell marker A2B5 (C) and neuron marker h-III tubulin (F), but coexpressed
astrocyte markers S-100h (D) and GFAP (E). After transplantation into adult rat spinal cord, human-derived CD44+ cells, as identified by human-specific
nuclear antibody (hNUC) continued to divide as implicated by Ki-67 staining (AV–CV, green). When these cells differentiated, they expressed astrocyte markers
such as GFAP (DV–FV), but not markers of neuronal or oligodendrocytic lineage (not shown). Scale bar in A–F, 100 Am; AV, 500 Am, BV–CV, 50 Am.
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ogies of mature oligodendrocytes (Fig. 7I), while cells
overexpressing CD44 failed to mature confirming that the
block in maturation seen in vivo is due to the direct effect
of CD44 on glial progenitors (Fig. 7I). Cells overexpress-
ing CD44 did not spontaneously differentiate into astro-
cytes but required additional signals such as LIF (data not
shown).
Overall, our data suggest that CD44 overexpression in
glial progenitors inhibits their maturation to oligodendro-
cytes and increase the number of astrocytes present in vivo.
CD44 labels astrocyte precursors in human fetal tissue
Our results and those of others (Alfei et al., 1999)
suggest that CD44 can be used to prospectively identify
astrocyte precursors in chick, rat, and mouse. To determine
whether a similar strategy can be used to isolate precursors
from human fetal cells, we obtained commercially available
mixed cultures of neural cells derived from 18–22-week
human fetuses, and examined the properties of CD44+ cells.
CD44-labeled cells were a population of dividing cells
(Figs. 8A,B) and a subset coexpressed astrocyte markers
such as S-100h (N90%, Fig. 8D). At this time, most CD44+
cells were GFAP. However, after growth in human neural
precursor cell medium in the presence of 1% fetal bovine
serum (ScienCell Research Laboratories) for 10–16 days,
virtually all CD44+ cells acquired GFAP expression (Fig.
8E). Undifferentiated CD44+ cells did not coexpress GRP
cell markers such as A2B5 (Fig. 8C) or neuronal markers
such as h-III tubulin (Fig. 8F). No double labeling of
CD44+ cells with oligodendrocyte markers Nkx2.2, Olig2,
or GalC was observed (data not shown, see also Mayer-
Proschel et al., 2002), suggesting the human CD44+ cells
are restricted to the astrocytic lineage. To confirm that this
restriction persisted after transplantation, we purified CD44-
expressing human cells from human fetal tissue samples
obtained from ScienCell Research Laboratories and trans-
planted them into adult rat spinal cord. As with rodent into
rodent transplants, we found that many of the human
CD44+ cells, as detected by staining of human specific
nuclei (hNUC) in the host spinal cord, expressed Ki-67
(Figs. 8AV–CV), an indicator for mitosis and proliferation.
Many of these human cells differentiated into GFAP-
expressing astrocytes 2 weeks posttransplantation (Figs.
8DV–FV), but no cell appeared to have differentiated into
neurons or oligodendrocytes as assessed by double labeling
with NeuN, h-III tubulin, Nkx2.2, or Olig2 (data not
shown).Discussion
We have shown that astrocytes and astrocyte precursors
are present at early developmental ages in the developing
brain and can be distinguished from multipotent stem cellsand other glial precursors by the expression of CD44, S-
100h, GLAST, and the absence of markers characteristic of
NEP cells (Sox2, Sox1), neuronal lineage (h-III tubulin,
PSA-NCAM or E-NCAM, neurofilament, microtubule-
associated protein 2 or MAP2), and GRP cells (A2B5,
NG2, PDGFRa, Olig2). CD44 and S-100h double-immu-
noreactive cells can be readily distinguished from radial
glial cells based on their morphology and distribution in
vivo and the absence of detectable levels of the radial glial
marker RC1 (Liu et al., 2002). However, it is difficult to
distinguish between these populations in culture as radial
glial morphology is significantly altered and RC1 or RC2
expression in vitro cannot be attributed to radial glial cells
alone.
We have taken advantage of the availability of
antibodies against the extracellular epitope CD44, to
isolate the CD44 immunoreactive population from rodent
and human tissue, and to assess their properties in vitro
and in vivo. Our results show that CD44+ ARP cells
harvested from E14.5 and later stages of development are
a dividing population of cells that can be maintained in
culture over multiple passages and are biased in their
differentiation capacity to generate GFAP+ astrocytes in
clonal culture and after transplantation into the adult
spinal cord. The behavior of ARPs is in contrast to the
behavior of GRP cells or NRP cells transplanted under
identical conditions, which will readily generate oligo-
dendrocytes and mature neurons (Han et al., 2002, 2004),
suggesting that the bias in differentiation observed is a
reflection on the intrinsic potential of the CD44+
precursor cell. Essentially identical results were obtained
when human fetal cells were used as a source to harvest
CD44+ astrocyte precursors, suggesting that CD44 is a
useful marker in chick (Alfei et al., 1999), rodent, and
human tissue. In our clonal analysis of CD44+ cells, we
have found that the majority of CD44+ sorted cells only
give rise to astrocytes but not cells of other lineages,
although we saw occasional differentiation of neuronal or
oligodendrocytic lineage. It is therefore unlikely that
these cells are multipotent stem cells. However, since
plasticity of astrocytes has been reported (Kondo and
Raff, 2000) and we have not checked all conditions, we
cannot rule out the possibility that some cells may be
more developmentally plastic or acquire such plasticity
under specific culture conditions (see review Liu and
Rao, 2003b).
The CD44+ ARP cell differs from the cell identified by
Mi and Barres (1999) in the immunoreactivity to A2B5 and
from the precursor identified by Seidman et al. (1997) in
that this is not immortalized. We note that Whittemore et al.
have reported that human neural stem cells upon repeated
passaging will generate a population of cells that are
restricted to differentiating into astrocytes after transplanta-
tion (Cao et al., 2001). While CD44 expression was not
demonstrated, the culture conditions, differentiation ability,
and absence of GFAP expression suggest that these cells
Y. Liu et al. / Developmental Biology 276 (2004) 31–4644may be similar or identical though definitive proof will
require direct comparisons.
Horner et al. (2000) have described proliferating cells in
the adult rat spinal cord. These cells possess the properties
of glial precursors and can give rise to both oligodendro-
cytes and astrocytes. These cells appear to resemble GRP
cells in their expression of Olig genes, Nkx2.2, NG2, and
absence of mature markers of oligodendrocytes as well as
markers of more primitive stem cells such as Sox1 and Sox2
(Talbott et al., in press). Whether they differentiate into
astrocytes via a CD44+ stage remains to be determined.
Based on the timing and distribution of CD44 expres-
sion, we hypothesized that at least a subset of CD44+ ARP
cells may arise from the A2B5+/CD44 GRPs, and our
results support this idea. A2B5+ cells generate CD44+ cells
in mass and clonal cultures (Fig. 3). The acquisition of
CD44 precedes the acquisition of GFAP, and CD44 and
GFAP are coexpressed subsequently in culture. Occasional
transitional A2B5+/CD44+ cells can be identified in culture,
which further suggests a sequential process of differ-
entiation. Equally importantly, A2B5+/CD44 sorted cells
can be transplanted in vivo, and these cells differentiate intoFig. 9. Astrocyte differentiation in the CNS. Neuroepithelial stem cells (NEP), ra
generate astrocytes. Astrocyte-restricted precursor (ARP), as assessed by CD44 exp
astrocytes. Note that while radial glia do not normally express CD44, we do not kn
overexpression prevents glial precursors from differentiating into oligodendrocyteCD44+ cells, which subsequently acquire GFAP immuno-
reactivity (Fig. 5).
Our hypothesis that at least some astrocytes arise via
the generation of CD44+ ARPs that are derived from
A2B5+ cells is further supported by the data from
CNP-CD44 transgenic mice. In this mouse model, the
CNP promoter drives specific expression of CD44 in
glial progenitors (or GRP cells, Tuohy et al., 2004).
Although the CNP promoter has been shown to be
active as early as E12.5 in mice (Chandross et al.,
1999), the increase in CD44 expression likely does not
affect embryos until E18 (Tuohy et al., 2004), when
glial precursors choose their fate to enter either into
oligodendrocyte lineage or astrocyte lineage. Misexpres-
sion of CD44 in this progenitor population results in
interference with fate determination and leads to an
increase in the number of O4 and GalC immunoreactive
cells and a demyelination phenotype (Tuohy et al.,
2004), suggesting a failure for oligodendrocyte precur-
sors to mature beyond the stage of GalC acquisition, a
developmental switching point between oligodendrocytic
and astrocytic fates (Gregori et al., 2002). In addition,dial glia, and glial-restricted precursor cells (GRP) have all been shown to
ression, might be one of the intermediate precursors that give rise to mature
ow whether they express CD44 as they mature to become astrocytes. CD44
s but does not prevent differentiation into astrocytes.
Y. Liu et al. / Developmental Biology 276 (2004) 31–46 45this increase in O4 and GalC is accompanied by a
dramatic increase in GFAP immunoreactivity and a 10-
fold increase in the number of O4+/GFAP+ and GalC+/
GFAP+ cells compared to WT animals (Fig. 6; Tuohy
et al., 2004), indicating that in this CD44 misexpression
model, an alteration in cell fate from oligodendrocyte to
astrocyte has occurred, which subsequently resulted in
the acquisition of astrocyte marker GFAP in oligoden-
drocyte precursors. Interestingly, similar transition from
an oligodendrocyte to astrocyte fate was also observed
in other genetically manipulated animal models. In
Olig1/2 double-knockout mice (Lu et al., 2002; Zhou
and Anderson, 2002), an overactivation or loss of
fibroblast growth factor receptor 3 (FGFR3) function
resulted in alteration of the numbers of both oligoden-
drocytes and astrocytes (Lin et al., 2003; Oh et al.,
2003; Pringle et al., 2003). While our transgenic mouse
data is consistent with our hypothesis, final confirmation
will require a direct demonstration in vivo using
conditional promoters and Cre-Lox systems that manip-
ulate the A2B5+ GRP cells. Experiments are in progress
to generate the appropriate tools.
While the indirect data taken together with the culture
and transplant experiments provide strong support for the
hypothesis that some astrocytes are derived from CD44+
ARP cells that are derived from GRP cells in vivo, we
emphasize, however, that our data (summarized in Fig. 9)
do not suggest that all astrocytes are derived from a GRP
cell. To the contrary, our results are consistent with the
idea that more than one lineage of astrocytes are likely
present with the GRP-derived astrocyte lineage being a
subset of the total number of astrocytes. We do not as
yet know which cell(s) contributes to the remaining
astrocyte population, though based on the early distribu-
tion of GFAP expression (Liu et al., 2002), the
demonstration of a transition of radial glia to astrocytes
(Voigt, 1989) and the maturation of radial glia into
astrocytes in vitro (Anton et al., unpublished) all suggest
that a subset of astrocytes are derived from radial glia.
Whether these astrocytes also go through additional
precursor cell stages and whether these precursors express
stage-specific markers remain to be determined. Deter-
mining the relative contribution of distinct lineages
requires developing appropriate assays, markers, and
genetically manipulated animals and will be a focus of
future experiments.
Overall, our data suggest that, during embryonic
development, a subset of astrocytes is generated via a
sequential process of differentiation that involves stem
cell–GRP–ARP to astrocyte differentiation. Cells at each
stage can be distinguished from each other using stage-
specific markers while their differentiation ability can be
tested in vitro and in vivo upon transplantation. Cell
surface epitopes, including CD44, can be used to harvest
selected populations of cells. Future experiments will be
directed at identifying the lineage relationship, if any,between radial glia and GRP cells, and characterizing
properties that distinguish astrocytes derived from distinct
developmental lineages.Acknowledgments
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